Nuvation Bio, Inc. (NUVB)
3.99
-0.07
(-1.72%)
USD |
NYSE |
Nov 13, 16:00
3.98
-0.01
(-0.25%)
Pre-Market: 19:59
Nuvation Bio Total Liabilities (Quarterly) : 550.42M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 550.42M |
| June 30, 2026 | 490.64M |
| March 31, 2026 | 290.68M |
| December 31, 2025 | 289.11M |
| September 30, 2025 | 275.68M |
| June 30, 2025 | 274.32M |
| March 31, 2025 | 73.03M |
| December 31, 2024 | 76.84M |
| September 30, 2024 | 68.86M |
| June 30, 2024 | 337.60M |
| March 31, 2024 | 19.08M |
| December 31, 2023 | 16.36M |
| September 30, 2023 | 19.28M |
| Date | Value |
|---|---|
| June 30, 2023 | 16.78M |
| March 31, 2023 | 15.99M |
| December 31, 2022 | 17.06M |
| September 30, 2022 | 18.55M |
| June 30, 2022 | 26.66M |
| March 31, 2022 | 28.24M |
| December 31, 2021 | 30.15M |
| September 30, 2021 | 28.42M |
| June 30, 2021 | 25.33M |
| March 31, 2021 | 25.72M |
| December 31, 2020 | 6.708M |
| September 30, 2020 | 0.974M |
| June 30, 2020 | 0.1471M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.24B |
| Johnson & Johnson | 115.90B |
| Merck & Co., Inc. | 87.83B |
| Bristol Myers Squibb Co. | 65.37B |
| ANI Pharmaceuticals, Inc. | 930.55M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 778.39M |
| Shareholders Equity (Quarterly) | 227.98M |
| Debt to Equity Ratio | 2.053 |
| Current Ratio | 7.454 |
| Net Debt Paydown Yield | -2.68% |